Re: Farmas USA
Lo de Omeros no pinta bien... caída de ventas del 90% desde otoño.
New Symphony Health Data Showing 90% Decline In Sales Of Omidria
Sales of Omeros' principal commercial product have fallen dramatically in the past two months. According to sales data just released from Symphony Health, OMIDRIA sales fell 87% in the month of January and over 90% from the November 2017 peak. FourWorld believes a sudden collapse in revenue will result in financial deterioration for Omeros that could be significant enough to trigger a Material Adverse Change or a covenant breach.
OMER